| View |
|
DRP-10878-08
|
Clopidogrel (as bisulfate)
|
Clotstop
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
25 April 2024
|
10 December 2026
|
| View |
|
DRP-10892-06
|
Zoledronic acid (as monohydrate)
|
Osteozol
|
800 mcg/ mL (4 mg/ 5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Bisphosphonate
|
Aroma Ilac San. LTD. STI
|
Turkey
|
CLIDP Conversion
|
28 April 2024
|
14 December 2026
|
| View |
|
DRP-10900-05
|
Levetiracetam
|
Epiloz
|
100mg/mL (500mg/5mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Antiepileptic
|
Aroma Ilac San. LTD. STI
|
Turkey
|
CLIDP Conversion
|
26 April 2024
|
14 December 2026
|
| View |
|
DRP-10952-05
|
Ketoanalogues + Essential Amino Acids
|
Ketolit
|
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
GLOBELA PHARMA PRIVATE LIMITED
|
India
|
CLIDP Conversion
|
24 April 2024
|
22 December 2026
|
| View |
|
DRP-10962-04
|
Etoricoxib
|
Medicoxib
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug (Selective COX-2 Inhibitor)
|
ACME Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 April 2024
|
23 December 2026
|
| View |
|
DRP-11022-02
|
Omeprazole (as sodium)
|
Omepravin
|
40 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor (PPI)
|
Mason Pharma
|
India
|
CLIDP Conversion
|
30 April 2024
|
29 April 2027
|
| View |
|
DRP-11047-01
|
Telmisartan
|
Merit
|
80 mg
|
Tablet
|
Alu/Alu Blister Pack x 10's / (Box of 30's)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
19 January 2027
|
| View |
|
DRP-11108-04
|
Butamirate Citrate
|
Atussin
|
50 mg
|
Film-coated Sustained-release Tablet
|
Antitussive
|
Orion Pharma Ltd.
|
Bangladesh
|
CLIDP Conversion
|
24 April 2024
|
03 February 2027
|
| View |
|
DRP-11151-04
|
Cefuroxime (as axetil)
|
Regixime
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
18 April 2024
|
08 February 2027
|
| View |
|
DRP-11155-01
|
Octreotide (as acetate)
|
Ocreon 50
|
50 mcg/mL
|
Solution for Injection (IV Infusion/ SC)
|
Hypothalamic Hormone (Somatostatin and Analogues)
|
United Biotech Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 April 2024
|
08 February 2027
|
| View |
|
DRP-11227-01
|
Paracetamol
|
Kidiron-250
|
250 mg/ 5 mL
|
Suspension (Orange Flavor)
|
Antipyretic / Analgesic
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
15 February 2027
|
| View |
|
DRP-11238-01
|
Paracetamol + Ibuprofen
|
None
|
325 mg/ 200mg
|
Capsule
|
Antipyretic-Analgesic/ Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 April 2024
|
16 February 2027
|
| View |
|
DRP-11789-07
|
Dapagliflozin
|
Catania
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 April 2024
|
29 April 2027
|
| View |
|
DRP-11789-08
|
Dapagliflozin
|
Dhaploff
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 April 2024
|
29 April 2027
|
| View |
|
DRP-1183-03
|
Pioglitazone (as hydrochloride)
|
Goglitazone 15
|
15 mg
|
Tablet
|
Blood Glucose Lowering Drug (Thiazolidinedione)
|
Umedica Laboratories Pvt. Ltd
|
|
CLIDP Conversion
|
24 April 2024
|
16 December 2028
|
| View |
|
DRP-1184-03
|
Pioglitazone (as hydrochloride)
|
Coglitazone 30
|
30 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 April 2024
|
16 December 2028
|
| View |
|
DRP-11851-07
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Duokaz
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
10 May 2027
|
| View |
|
DRP-11880-02
|
Atorvastatin (as calcium )
|
None
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
18 May 2027
|
| View |
|
DRP-11882-03
|
Salbutamol (as sulfate) + Ipratropium (as bromide)
|
Gopra
|
2.5 mg/500 mcg per 2.5 mL
|
Solution for Inhalation
|
Adrenergics in combination with anticholinergic
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
29 April 2024
|
16 May 2027
|
| View |
|
DRP-11926-03
|
Meropenem
|
Merotam
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
24 April 2024
|
20 May 2027
|